المؤلفون: Camus V; Department of Hematology, Centre Henri Becquerel, Rouen, France., Thieblemont C; Hematology Department, Hospital Saint-Louis, Paris, France., Gaulard P; Department of Pathology and InsermU955, University Hospital Henri Mondor, Créteil, France., Cheminant M; Service d'Hematologie adultes, Hopital Universitaire Necker Enfants Malades, AP-HP, Paris, France., Casasnovas RO; Department of Hematology, CHU Dijon-Bourgogne and INSERM 1231, Dijon, France., Ysebaert L; IUCT Oncopole, Toulouse, France., Damaj GL; CHU de Caen Normandie, Normandie, France., Guidez S; Service d'Hématologie, CHU de Poitiers, Poitiers, France., Pica GM; Department of Hematology, Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France., Kim WS; Samsung Medical Center, Seoul, South Korea., Lim ST; National Cancer Centre Singapore, Singapore., Andre M; Department of Hematology, CHU UCL Namur, Yvoir, Belgium., Gutiérrez N; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Penarrubia MJ; Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Staber PB; Division of Hematology, Department of Medicine I, Medical University Vienna, Vienna, Austria., Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, Australia., Hüttmann A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Stefoni V; Policlinico Sant'Orsola-Malpighi, Bologna, Italy., Tucci A; Hematology Division, Spedali Civili di Brescia, Brescia, Italy., Fogarty P; Biostatistics Department, LYSARC, Hôpital Lyon-Sud, Pierre-Bénite, France., Farhat H; Department of Oncology-Hematology, Centre Hospitalier de Versailles, Le Chesnay, France., Abraham J; Department of Hematology, Centre Hospitalo-universitaire (CHU) Dupuytren, Limoges, France., Abarah W; Department of Hematology, Grand Hôpital de l'Est Francilien, Meaux, France., Belmecheri F; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Ribrag V; Department of Hematology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France., Delfau-Larue MH; Department of Immunobiology and InsermU955, University Hospital Henri Mondor, Créteil, France., Cottereau AS; Department of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Cité University, Paris, France., Itti E; Department of Nuclear Medicine, CHU Henri Mondor, Créteil, France., Li J; Bristol Myers Squibb Company, Princeton, NJ., Delarue R; Service d'Hematologie adultes, Hopital Universitaire Necker Enfants Malades, AP-HP, Paris, France., de Leval L; Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Morschhauser F; Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France., Bachy E; Hospices Civils De Lyon, Lyon, France.; Claude Bernard Lyon 1 University, Lyon, France.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 10; Vol. 42 (14), pp. 1612-1618. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/drug therapy , Lymphoma, T-Cell, Peripheral*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Cyclophosphamide*/administration & dosage , Cyclophosphamide*/therapeutic use , Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Vincristine*/administration & dosage , Vincristine*/therapeutic use , Prednisone*/administration & dosage , Prednisone*/therapeutic use , Depsipeptides*/administration & dosage , Depsipeptides*/therapeutic use, Humans ; Middle Aged ; Male ; Female ; Aged ; Adult ; Progression-Free Survival

SCR Protocol: CHOP protocol

المؤلفون: Bachy E; Hematology Department, Lyon Sud Hospital and Claude Bernard Lyon 1 University, Lyon, France., Savage KJ; Division of Medical Oncology, University of British Columbia, BC Cancer, Vancouver, Canada., Huang H; Sun Yat-Sen University Cancer Center, Guangzhou, China., Kwong YL; Queen Mary Hospital, Hong Kong SAR, China., Gritti G; ASST Papa Giovanni XXIII, Bergamo, Italy., Zhang Q; Harbin Medical University Cancer Hospital, Harbin, China., Liberati AM; Azienda Ospedaliera Santa Maria Terni, Terni, Italy., Cao J; Fudan University Shanghai Cancer Center, Shanghai, China., Yang H; The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China., Hao S; Xin Hua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China., Hu J; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou, China., Zhou K; Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Petrini M; Azienda Ospedaliero Universitaria Pisana, Stabilimento di Santa Chiara, Pisa, Italy., Russo F; Ospedale Maggiore, Ematologia e Centro Trapianti Midollo Osseo (CTMO), AOU Parma, Parma, Italy., Zhang H; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Sang W; The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Ji J; West China Hospital, Sichuan University, Chengdu, China., Ferreri AJM; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy., Damaj GL; Institut d'Hematologie de Basse Normandie, Caen, France., Liu H; Beijing Hospital, Beijing, China., Zhang W; Peking Union Medical College Hospital, Beijing, China., Ke X; Peking University Third Hospital, Beijing, China., Ghiggi C; Ospedale Policlinico San Martino, Genoa, Italy., Huang S; BeiGene (Shanghai) Co Ltd, Shanghai, China., Li X; BeiGene (Shanghai) Co Ltd, Shanghai, China., Yao H; BeiGene (Shanghai) Co Ltd, Shanghai, China., Paik J; BeiGene USA, Inc, San Mateo, CA., Novotny W; BeiGene USA, Inc, San Mateo, CA., Zhou W; BeiGene (Shanghai) Co Ltd, Shanghai, China., Zhu H; BeiGene (Shanghai) Co Ltd, Shanghai, China., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli,' Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.

المصدر: Blood advances [Blood Adv] 2023 Aug 22; Vol. 7 (16), pp. 4435-4447.

نوع المنشور: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Mycosis Fungoides*/drug therapy , Lymphoma, T-Cell, Cutaneous*/drug therapy , Skin Neoplasms*/drug therapy, Humans ; Killer Cells, Natural/pathology

المؤلفون: Cartron G; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France., Bachy E; Department of Hematology, University Hospital, Lyon, France., Tilly H; Department of Hematology, U1245, Henri Becquerel Institute, Rouen, France., Daguindau N; Departement of Hematology, Annecy-Genevois Hospital Centre, Annecy, France., Pica GM; Departement of Hematology, Hospital Centre, Chambery, France., Bijou F; Departement of Hematology, Bergonié Institute, Bordeaux, France., Mounier C; Departement of Hematology, Oncology and Hematology Institute, Sainte-Etienne, France., Clavert A; Departement of Hematology, University Hospital, Angers, France., Damaj GL; Departement of Hematology, University Hospital, Caen, France., Slama B; Departement of Hematology, Hospital Centre, Avignon, France., Casasnovas O; Departement of Hematology, University Hospital, Dijon, France., Houot R; Departement of Hematology, University Hospital, Rennes, France., Bouabdallah K; Departement of Hematology, University Hospital, Bordeaux, France., Sibon D; Departement of Hematology, Necker Hospital, APHP, Paris, France., Fitoussi O; Departement of Hematology, Polyclinic Bordeaux Nord, Bordeaux, France., Morineau N; Departement of Hematology, Hospital Centre, La Roche-sur-Yon, France., Herbaux C; Department of Hematology, UMR CNRS 5535, University Hospital, Montpellier, France., Gastinne T; Departement of Hematology, University Hospital, Nantes, France., Fornecker LM; Departement of Hematology, University Hospital, Strasbourg, France., Haioun C; Departement of Hematology, Lymphoma Malignancies Unit, Henri Mondor Hospital, APHP, Créteil, France., Launay V; Departement of Hematology, Hospital Centre, Saint-Brieuc, France., Araujo C; Departement of Hematology, Hospital Centre, Bayonne, France., Benbrahim O; Departement of Hematology, Hospital Centre, Orléans, France., Sanhes L; Departement of Hematology, Hospital Centre, Perpignan, France., Gressin R; Departement of Hematology, University Hospital, Grenoble, France., Gonzalez H; Departement of Hematology, Hospital Centre, Pontoise, France., Morschhauser F; Department of Hematology, ULR 7365 GRITA, University Hospital, Lille, France., Ternant D; UMR7292, University François-Rabelais, Tours, France., Xerri L; Department of Biopathology, Paoli-Calmettes Institue, Marseille, France., Tarte K; UMR1236, Department of Immunology, Rennes I University, Rennes, France., Pranger D; Department of Haematology, Hospital Centre, Charleroi, Belgium.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jul 01; Vol. 41 (19), pp. 3523-3533. Date of Electronic Publication: 2023 Apr 18.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/pathology, Humans ; Rituximab ; Tumor Burden ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Progression-Free Survival

المؤلفون: Camus V; Centre Henri Becquerel, Department of Hematology, Rouen, France., Thieblemont C; CHU St Louis, Hematology, Paris, France., Gaulard P; University Hospital Henri Mondor, Department of Pathology and InsermU955, Créteil, France, France., Cheminant M; Hopital Universitaire Necker Enfants Malades, Service d'Hematologie adultes, Paris, France., Casasnovas R; Dijon University Hospital, Hematology, Dijon, France., Ysebaert L; IUCT Oncopole, Hematology, Toulouse, France., Damaj GL; CHU de Caen Normandie, Department of Hematology, Caen, France., Guidez S; CHU de Poitiers, Service d'Hématologie, Poitiers, France., Pica GM; Centre Hospitalier Métropole Savoie Chambéry, Department of Hematology, Chambéry, France., Kim WS; Samsung Medical Center, Seoul, Korea., Lim ST; National Cancer Centre Singapore, Singapore, Singapore., Andre M; CHU UCL Namur, Department of Hematology, Yvoir, Belgium., Gutiérrez N; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Penarrubia MJ; Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Staber PB; Medical University Vienna, Division of Hematology, Department of Medicine I, Vienna, Austria., Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, Australia., Hüttmann A; West German Cancer Center Essen, University Hospital Essen, University of Duisburg-Essen, Department of Hematology and Stem Cell Transplantation, Essen, Germany., Stefoni V; Policlinico Sant'Orsola-Malpighi, Bologna, Italy., Rossi G; Spedali Civili di Brescia, Hematology Division, Brescia, Italy., Delfau-Larue M; University Hospital Henri Mondor, Department of Immunobiology and InsermU955, Créteil, France., Cottereau A; Cochin Hospital, AP-HP, Paris Cité University, Department of Nuclear Medicine, Paris, France., Itti E; CHU Henri Mondor, Department of Nuclear Medicine, Créteil, France., Li J; Bristol Myers Squibb Company, Princeton, USA., Delarue R; Hopital Universitaire Necker Enfants Malades, Service d'Hematologie adultes, Paris, France., de Leval L; Lausanne University Hospital and Lausanne University, Institute of Pathology, Lausanne, Switzerland., Morschhauser F; Univ. Lille, CHU Lille, ULR 7365, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France., Bachy E; Hospices Civils De Lyon, Lyon, France.

المصدر: Hematological oncology [Hematol Oncol] 2023 Jun; Vol. 41 Suppl 2, pp. 77-78.

نوع المنشور: Congress; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/therapy, Humans ; Switzerland ; Congresses as Topic

المؤلفون: Polverelli N; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy. Electronic address: nicola.polverelli@unibs.it., Hernández-Boluda JC; Department of Hematology, Hospital Clínico Universitario, Valencia, Spain., Czerw T; Department of Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Barbui T; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., D'Adda M; Hematology Division, Department of Oncology, ASST Spedali Civili di Brescia, Brescia, Italy., Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Ditschkowski M; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany., Harrison C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Kröger NM; University Medical Center Hamburg, Hamburg, Germany., Mesa R; Mays Cancer Center at UT Health San Antonio, San Antonio, TX, USA., Passamonti F; Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Varese, Italy., Palandri F; Institute of Hematology L and A Seràgnoli, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rondelli D; Blood and Marrow Transplant Program, and Center for Global Health, University of Illinois at Chicago, Chicago, IL, USA., Vannucchi AM; Center for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Robin M; Hôpital Saint-Louis, APHP, Université de Paris Cité, Paris, France., Colecchia A; Gastroenterology Unit, University Hospital of Modena, Modena, Italy., Grazioli L; Department of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy., Damiani E; 2nd Division of General Surgery, Department of Medical and Surgical Sciences, ASST Spedali Civili di Brescia, Brescia, Italy., Russo D; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Brady J; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Patch D; Hepatology and Liver Transplantation, Royal Free London NHS Foundation Trust, London, UK., Blamek S; Department of Radiotherapy, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Damaj GL; Unit of Hematology, Centre Hospitalier Universitaire de Caen, University of Caen-Normandie, Caen, France., Hayden P; Department of Haematology, Trinity College Dublin, St James's Hospital, Dublin, Ireland., McLornan DP; Department of Stem Cell Transplantation and Haematology, University College London Hospitals, London, UK., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France. Electronic address: ibrahim.yakoubagha@chru-lille.fr.

المصدر: The Lancet. Haematology [Lancet Haematol] 2023 Jan; Vol. 10 (1), pp. e59-e70. Date of Electronic Publication: 2022 Dec 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/complications , Primary Myelofibrosis*/therapy , COVID-19*/complications , Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/therapy , Thrombosis*/complications, Humans ; Splenomegaly/etiology ; Transplantation Conditioning

المؤلفون: Nerich V; Department of Pharmacy, University Hospital, Besançon, France.; INSERM, EFS-BFC, UMR1098, University of Franche-Comté, Besançon, France., Guyeux C; Femto-ST Institute, UMR 6174 CNRS, University of Bourgogne Franche-Comté, Besançon, France., Henry-Amar M; French Center on eHealth, North-West Region Data Processing Center and French National League Against Cancer Clinical Research Platform, CCC François Baclesse, Caen, France., Couturier R; Femto-ST Institute, UMR 6174 CNRS, University of Bourgogne Franche-Comté, Besançon, France., Thieblemont C; Hemato-Oncology Unit, Saint-Louis University Hospital Center, Public Hospital Network of Paris, Paris, France., Ribrag V; Hematology Unit, Gustave Roussy Cancer Campus, Villejuif, France., Tilly H; Hematology Department and French Institute of Health and Medical Research Unit 1243, Henri Becquerel Center, Rouen, France., Haioun C; Lymphoid Malignancies Unit, Henri Mondor University Hospital Center, Public Hospital Network of Paris, Créteil, France., Casasnovas RO; Hematology Unit and French Institute of Health and Medical Research Unit 1231, Bocage Hospital, Dijon Bourgogne Regional University Hospital Center, Dijon, France., Morschhauser F; Hematology Transfusion Institute, Claude Huriez Hospital, Lille Regional University Hospital Center, Lille, France., Feugier P; Hematology Unit, Brabois Hospital, Nancy University Hospital Center, Vandoeuvre-lès-Nancy, France., Sibon D; Hematology Unit, Necker University Hospital for Sick Children, Public Hospital Network of Paris, Paris, France., Ysebaert L; Oncopole, Toulouse University Cancer Institute, Toulouse, France., Nicolas-Virelizier E; Hematology Unit, Léon Bérard Center, Lyon, France., Broussais-Guillaumot F; Clinical Research Department-Lymphoma Study Association, Lyon South Hospital Center, Pierre-Bénite, France., Damaj GL; Basse-Normandy Hematology Institute, Côte de Nacre Regional University Hospital Center, Caen, France., Jais JP; Laboratory of Biostatistics, Paris V University-Descartes, Paris, France., Salles G; Faculty of Medicine, Claude Bernard University, Lyon, France.; Hematology Department, Lyon South Hospital Center, Pierre-Bénite, France., Woronoff-Lemsi M; INSERM, EFS-BFC, UMR1098, University of Franche-Comté, Besançon, France.; Department of Clinical Research and Innovation, University Hospital, Besançon, France., Mounier N; Onco-Hematology Unit, l'Archet Hospital, Nice University Hospital Center, University of Côte d'Azur, Nice, France.

المصدر: Cancer [Cancer] 2022 Feb 01; Vol. 128 (3), pp. 519-528. Date of Electronic Publication: 2021 Oct 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Lymphoma* , Lymphoma, Non-Hodgkin*/therapy, Cross-Sectional Studies ; Financial Stress ; Health Care Costs ; Humans ; Retrospective Studies ; Survivors ; Transplantation, Autologous

المؤلفون: Pastoret C; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France., Desmots F; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France., Drillet G; Service d'Hématologie Clinique, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France., Le Gallou S; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France., Boulland ML; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France., Thannberger A; Service d'Hématologie Clinique, Hôpital de Saint Malo, Saint Malo, France., Doncker AV; Hôpital Privé Sévigné, Cesson-Sévigné, France., Salaun V; Laboratoire d'Hématologie and., Damaj GL; Service d'Hématologie Clinique, CHU de Caen Normandie, Caen, France., Veyrat-Masson R; Laboratoire d'Hématologie and., Tournilhac O; Service d'Hématologie Clinique, CHU de Clermont-Ferrand, Clermont-Ferrand, France; and., Moignet A; Service d'Hématologie Clinique, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France.; Centre d'Investigation Clinique (CIC) 1414, Rennes, France., Pangault C; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France., Roussel M; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France., Fest T; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France., Lamy T; INSERM, Unité Mixte de Recherche (UMR) 1236, Etablissement Français du sang Bretagne, Université Rennes 1, Rennes, France.; Service d'Hématologie Clinique, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France.; Centre d'Investigation Clinique (CIC) 1414, Rennes, France.

المصدر: Blood [Blood] 2021 Jun 10; Vol. 137 (23), pp. 3237-3250.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, DNA-Binding Proteins/*metabolism , Dioxygenases/*metabolism , Killer Cells, Natural/*metabolism , Lymphoma, T-Cell/*metabolism , Neoplasm Proteins/*metabolism , Receptors, KIR/*metabolism , STAT3 Transcription Factor/*metabolism, Aged ; Chronic Disease ; DNA-Binding Proteins/genetics ; Dioxygenases/genetics ; Female ; Hematopoietic Stem Cells/metabolism ; Humans ; Lymphoma, T-Cell/genetics ; Male ; Middle Aged ; Neoplasm Proteins/genetics ; Receptors, KIR/genetics ; STAT3 Transcription Factor/genetics

المؤلفون: Morschhauser F; Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU de Lille, Université de Lille, Lille, France. Electronic address: franck.morschhauser@chru-lille.fr., Tilly H; Department of Hematology and INSERM U1245, Centre Henri Becquerel and Rouen University, Rouen, France., Chaidos A; Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, Hammersmith Hospital & Imperial College Healthcare NHS Trust, London, UK., McKay P; Department of Hematology, Beatson West of Scotland Cancer Centre, Glasgow, UK., Phillips T; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA., Assouline S; Division of Hematology, Jewish General Hospital, Montreal, QC, Canada; Department of Oncology, McGill University, Montreal, QC, Canada., Batlevi CL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Campbell P; Department of Clinical Haematology, Barwon Health, University Hospital Geelong, Geelong, VIC, Australia., Ribrag V; Hematology Department, Gustave Roussy, Villejuif, France., Damaj GL; Hematology Institute, Hematologie Clinique, University Hospital School of Medicine, Caen, France., Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Jurczak W; Department of Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland., Kazmierczak M; Department of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland., Opat S; Haematology Department, Monash University, Melbourne, VIC, Australia., Radford J; Department of Medical Oncology, University of Manchester, Manchester, UK; NIHR Manchester Clinical Research Facility, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK., Schmitt A; Department of Hematology, Institut Bergonié, Bordeaux, France., Yang J; Clinical Development, Epizyme, Cambridge, MA, USA., Whalen J; Clinical Development, Epizyme, Cambridge, MA, USA., Agarwal S; Clinical Development, Epizyme, Cambridge, MA, USA., Adib D; Clinical Development, Epizyme, Cambridge, MA, USA., Salles G; Department of Hematology, Lyon-Sud Hospital, University of Lyon, Pierre-Bénite, France.

المصدر: The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1433-1442. Date of Electronic Publication: 2020 Oct 06.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Benzamides/*administration & dosage , Enhancer of Zeste Homolog 2 Protein/*genetics , Lymphoma, Follicular/*drug therapy , Pyridones/*administration & dosage, Adult ; Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Benzamides/adverse effects ; Biphenyl Compounds ; Female ; Humans ; Lymphoma, Follicular/genetics ; Lymphoma, Follicular/pathology ; Male ; Middle Aged ; Morpholines ; Mutation/genetics ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Progression-Free Survival ; Pyridones/adverse effects ; Treatment Outcome

المؤلفون: Alexandre J; PICARO Cardio-Oncology Program Department of Pharmacology Department of Cardiology Caen Hospital Medical School Caen-Normandy University Caen France., Cautela J; Unit of Heart Failure and Valvular Heart Diseases Department of Cardiology Nord Hospital Center for CardioVascular and Nutrition Research (C2VN) University Mediterranean Center of Cardio-Oncology (MEDI-CO Center) Assistance Publique - Hôpitaux de MarseilleAix-Marseille University Marseille France.; Mediterranean Group of Cardio-Oncology (gMEDICO) Marseille France., Ederhy S; UNICO-GRECO Cardio-Oncology Program Department of Cardiology Saint-Antoine Hospital Tenon Hospital Inserm 856 Assistance Publique - Hôpitaux de ParisSorbonne University Paris France., Damaj GL; Department of Hematology Caen Hospital Medical School Caen-Normandy University Caen France., Salem JE; UNICO-GRECO Cardio-Oncology Program Department of Pharmacology Centre d'Investigation Clinique Paris-Est Pitié-Salpêtrière Hospital Assistance Publique - Hôpitaux de ParisSorbonne University Paris France., Barlesi F; Drug Development Department (DITEP) Gustave RoussyParis-Saclay University Villejuif France., Farnault L; Departement of Hematology Conception HospitalAssistance Publique - Hôpitaux de MarseilleAix-Marseille University Marseille France., Charbonnier A; Departement of Hematology Paoli-Calmettes Cancer InstituteAix-Marseille University Marseille France., Mirabel M; Unit of Cardio-Oncology and Prevention European Georges Pompidou HospitalAssistance Publique - Hôpitaux de ParisSorbonne University Paris France., Champiat S; Drug Development Department (DITEP) Gustave RoussyParis-Saclay University Villejuif France., Cohen-Solal A; Department of Cardiology Lariboisière Hospital UMR-S 942 Assistance Publique - Hôpitaux de ParisParis University Paris France., Cohen A; UNICO-GRECO Cardio-Oncology Program Department of Cardiology Saint-Antoine Hospital Tenon Hospital Inserm 856 Assistance Publique - Hôpitaux de ParisSorbonne University Paris France., Dolladille C; PICARO Cardio-Oncology Program Department of Pharmacology Department of Cardiology Caen Hospital Medical School Caen-Normandy University Caen France., Thuny F; Unit of Heart Failure and Valvular Heart Diseases Department of Cardiology Nord Hospital Center for CardioVascular and Nutrition Research (C2VN) University Mediterranean Center of Cardio-Oncology (MEDI-CO Center) Assistance Publique - Hôpitaux de MarseilleAix-Marseille University Marseille France.; Mediterranean Group of Cardio-Oncology (gMEDICO) Marseille France.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2020 Sep 15; Vol. 9 (18), pp. e018403. Date of Electronic Publication: 2020 Sep 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Practice Guidelines as Topic*, Antineoplastic Agents/*toxicity , Cardiovascular Diseases/*chemically induced, Antineoplastic Agents/administration & dosage ; Cardiovascular Diseases/prevention & control ; Europe ; Humans ; Immunotherapy/adverse effects ; Neoplasms/drug therapy ; United States

المؤلفون: Clin B; INSERM U1086 « ANTICIPE », 14033, Caen Cedex, France. benedicte.clin14@orange.fr.; Université de Caen Normandie, Caen, France. benedicte.clin14@orange.fr.; Occupational Health Department, Service de Santé au Travail et Pathologie Professionnelle, C.H.U. (University Hospital) Côte de Nacre, CHU Caen, Caen, France. benedicte.clin14@orange.fr., Heutte N; CETAPS EA3832, Université de Rouen, Mont-Saint-Aignan, France.; Clinical Research Department, Centre François Baclesse, Caen, France., Boulanger M; INSERM U1086 « ANTICIPE », 14033, Caen Cedex, France., Troussard X; Service d'Hématologie Clinique, CHU de Caen, Caen, France.; Registre des Hémopathies Malignes de Basse-Normandie, Caen, France., Cornet E; Registre des Hémopathies Malignes de Basse-Normandie, Caen, France., Damaj GL; Service d'Hématologie Clinique, CHU de Caen, Caen, France., Bouvier V; INSERM U1086 « ANTICIPE », 14033, Caen Cedex, France., Guizard AV; INSERM U1086 « ANTICIPE », 14033, Caen Cedex, France., Launoy G; INSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.; Université de Caen Normandie, Caen, France., Licaj I; INSERM U1086 « ANTICIPE », 14033, Caen Cedex, France.; Clinical Research Department, Centre François Baclesse, Caen, France.; Department of Community Medicine, Faculty of Health Sciences, The UiT Arctic University of Norway, Tromsø, Norway.

المصدر: BMC research notes [BMC Res Notes] 2020 Jul 02; Vol. 13 (1), pp. 313. Date of Electronic Publication: 2020 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/psychology , Return to Work*, Adolescent ; Adult ; Anxiety ; Depression ; Fatigue ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Quality of Life ; Social Factors ; Young Adult